Health-Chem Corp
OTC:HCLC
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
H
|
Health-Chem Corp
OTC:HCLC
|
1.2k USD |
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
861.5B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.8B USD |
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
375.3B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
257.8B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
220.5B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
228.1B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
283.5B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
240.1B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Health-Chem Corp
Glance View
Health-Chem Corp. develops, manufactures and markets transdermal drug delivery systems. The company is headquartered in New York City, New York and currently employs 206 full-time employees. Transderm owns 98.5% of Hercon Laboratories Corporation, which develops and manufactures controlled release products for the pharmaceutical industry, at Transderm's Pennsylvania facility, to deliver a variety of drugs topically or transdermally. The firm has manufactured over-the-counter pharmaceutical and cosmetic products that are used to clean facial pores. These deep cleansing facial pore strips are designed to remove clogged dirt, oil and blackheads from the nose, chin, forehead and anywhere else on the face that needs deep cleaning. In addition to its nitroglycerin transdermal products, the Company is also developing transdermal products for hormone replacement therapies.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
Over the last 3 years, Health-Chem Corp’s Gross Margin has decreased from 29% to 24.4%. During this period, it reached a low of 23% on Sep 30, 1997 and a high of 30.6% on Jun 30, 1996.
